Does capecitabine maintenance therapy versus active monitoring confer a survival benefit after first-line treatment of metastatic colorectal cancer? A meta-analysis of randomized controlled trials

Ling Fan, Bobo Zheng(Shanxi Medical University), Tao Wu(Lanzhou Army General Hospital), Ying Jie(Beijing Tongren Hospital), Bo Chen(South China Agricultural University), Jian Chen(University of Science and Technology of China), Yumin Yue
Research Square
November 21, 2022
Cited by 0


Related Papers